Allied Moves to Become Leader in Psilocybin Space with Intent to Acquire Pacific Sun Fungi

“We were seeing many people coming through our healing retreats reporting the benefits of the micro dosing with psilocybin products. We put our best scientists to task to explore the pharmaceutical benefits of functional mushroom formulations. We truly believe that several pharma drug indications will be discovered with the products that we have. We are excited to begin this important research in the New Year.” said Calum Hughes, CEO and Founder of Allied Corp.

122420- Allied Moves to Become Leader in
Download • 80KB

Medical and Pharma Insider

A Program of FC Global Strategies LLC

383 Corona Street, Suite 589, Denver CO 80218 USA

Tel +1 303 478 4887



MedicalandPharmaInsider- (1).jpg
FC Global Strategies.png

©2021 Medical and Pharma Insider and FC Global Strategies LLC